导航自迷宫:ATG及其对神经退行性疾病的影响
Roshanak Amirian1,2, AmirHossein Merati1,2, Mehregan Babamohamadi3,4,2
1Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Molecular neurobiology
|December 6, 2025
概括
与自相关的基因 (ATG) 在神经退行性疾病 (NDs) 中至关重要. 了解ATG功能为这些具有挑战性的疾病提供了新的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 自对于细胞平衡至关重要,并与神经退行性疾病 (NDs) 有关.
- 神经退行性疾病具有多样化的机制和临床异质性,使治疗开发复杂化.
- 与自相关的基因 (ATG) 是自过程和疾病调节的核心.
研究的目的:
- 审查自相关基因 (ATG) 在神经退行性疾病 (NDs) 中的复杂作用.
- 确定分子信号网络,蛋白质与蛋白质相互作用和监管检查点作为潜在的治疗点.
- 为突出疾病建模,试验和临床翻译生物标志物的进展.
主要方法:
- 文献综述侧重于神经退行性疾病发病过程中的自相关基因 (ATG).
- 对疾病建模和自试验近期进展的分析.
- 探索生物标志物识别策略的探索.
主要成果:
- 与自相关的基因 (ATG) 在调节神经退行性疾病中的疾病特异性途径方面发挥着关键作用.
- 了解ATG的功能,相互作用和调节是开发向治疗的关键.
- 最近的进展有助于将与ATG相关的研究转化为临床应用.
结论:
- 对ATG的全面理解对于推进神经退行性疾病治疗方法至关重要.
- 跨学科的合作对于利用自的治疗潜力至关重要.
- 本综述为ATG和神经退行性疾病的未来研究和治疗开发提供了路线图.
相关概念视频
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


